Ajooni Biotech [AJOONI] vs BN Holdings [BNHOLDINGS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Ajooni Biotech Ltd. wins in 11 metrics, BN Holdings Ltd wins in 7 metrics, with 0 ties. Ajooni Biotech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ajooni Biotech Ltd. BN Holdings Ltd Better
P/E Ratio (TTM) 21.30 26.71 Ajooni Biotech Ltd.
Price-to-Book Ratio 0.77 5.01 Ajooni Biotech Ltd.
Debt-to-Equity Ratio 11.32 21.23 Ajooni Biotech Ltd.
PEG Ratio N/A -0.13 N/A
EV/EBITDA 11.17 71.58 Ajooni Biotech Ltd.
Profit Margin (TTM) 3.23% 8.31% BN Holdings Ltd
Operating Margin (TTM) 3.78% 11.63% BN Holdings Ltd
EBITDA Margin (TTM) 3.78% 11.63% BN Holdings Ltd
Return on Equity 5.51% 5.05% Ajooni Biotech Ltd.
Return on Assets (TTM) 3.58% 2.98% Ajooni Biotech Ltd.
Free Cash Flow (TTM) $-197.69M $-315.40M Ajooni Biotech Ltd.
1-Year Return -30.91% 121.74% BN Holdings Ltd
Price-to-Sales Ratio (TTM) 0.48 6.91 Ajooni Biotech Ltd.
Enterprise Value $803.44M $39.47B BN Holdings Ltd
EV/Revenue Ratio 0.53 7.85 Ajooni Biotech Ltd.
Gross Profit Margin (TTM) 22.46% 12.89% Ajooni Biotech Ltd.
Revenue per Share (TTM) $15 $117 BN Holdings Ltd
Earnings per Share (Diluted) $0.20 $13.31 BN Holdings Ltd
Beta (Stock Volatility) 0.44 0.63 Ajooni Biotech Ltd.

Ajooni Biotech Ltd. vs BN Holdings Ltd Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ajooni Biotech Ltd.-1.58%-1.06%-10.53%-7.65%-15.77%-13.63%
BN Holdings Ltd-6.39%-2.61%-5.30%22.11%136.19%246.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ajooni Biotech Ltd.-30.91%-6.40%-51.96%-49.27%-49.27%-49.27%
BN Holdings Ltd121.74%678.57%678.57%678.57%678.57%678.57%

Performance & Financial Health Analysis: Ajooni Biotech Ltd. vs BN Holdings Ltd

MetricAJOONIBNHOLDINGS
Market Information
Market Cap i₹733.76M₹38.60B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i369,15312,011
90 Day Avg. Volume i456,76315,565
Last Close₹3.74₹378.85
52 Week Range₹3.40 - ₹6.60₹104.00 - ₹419.95
% from 52W High-43.33%-9.79%
All-Time High₹85.85 (Feb 07, 2022)₹419.95 (Nov 12, 2025)
% from All-Time High-95.64%-9.79%
Growth Metrics
Quarterly Revenue Growth0.73%-0.05%
Quarterly Earnings Growth1.26%N/A
Financial Health
Profit Margin (TTM) i0.03%0.08%
Operating Margin (TTM) i0.04%0.12%
Return on Equity (TTM) i0.06%0.05%
Debt to Equity (MRQ) i11.3221.23
Cash & Liquidity
Book Value per Share (MRQ)₹5.53₹70.98
Cash per Share (MRQ)₹0.01₹0.69
Operating Cash Flow (TTM) i₹-198,640,000₹-2,593,269,000
Levered Free Cash Flow (TTM) i₹33.72M₹197.56M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Ajooni Biotech Ltd. vs BN Holdings Ltd

MetricAJOONI (Apr 26, 2026)BNHOLDINGS (Nov 13, 2025)
Price Ratios
P/E Ratio (TTM) i21.3026.71
Forward P/E iN/AN/A
PEG Ratio iN/A-0.13
Price to Sales (TTM) i0.486.91
Price to Book (MRQ) i0.775.01
Market Capitalization
Market Capitalization i₹733.76M₹38.60B
Enterprise Value i₹803.44M₹39.47B
Enterprise Value Metrics
Enterprise to Revenue i0.537.85
Enterprise to EBITDA i11.1771.58
Risk & Other Metrics
Beta i0.440.63
Book Value per Share (MRQ) i₹5.53₹70.98

Financial Statements Comparison: Ajooni Biotech Ltd. vs BN Holdings Ltd

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAJOONI (2025)BNHOLDINGS (2025)
Revenue/Sales i1.15B2.99B
Cost of Goods Sold i970.28M2.81B
COGS % of Revenue i84.6%94.0%
Gross Profit i176.64M180.67M
Gross Margin i15.4%6.0%
Research & Development i0N/A
Operating Income (EBIT) i29.03M106.15M
Operating Margin i2.5%3.5%
EBITDA i48.51M750.34M
EBITDA Margin i4.2%25.1%
Pre-Tax Income i43.29M216.61M
Pre-Tax Income % of Revenue i3.8%7.2%
Income Tax i9.57M19.06M
Income Tax % of Revenue i0.8%0.6%
Net Income (Profit) i33.72M197.56M
Profit Margin i2.9%6.6%

Balance Sheet & Liquidity Metrics

MetricAJOONI (2025)BNHOLDINGS (2025)
Cash & Equivalents i68.30M67.06M
Total Current Assets i620.04M2.98B
Total Current Assets % of Revenue i54.1%99.7%
Total Current Liabilities i48.21M2.27B
Total Current Liabilities % of Revenue i4.2%75.7%
Long-Term Debt i19.40M439.56M
Long-Term Debt % of Revenue i1.7%14.7%
Total Shareholders Equity i880.79M3.91B
Retained Earnings iN/A68.92M
Retained Earnings % of Revenue i0.0%2.3%
Property, Plant & Equipment i109.33M12.63M

Cash Flow Statement Comparison

MetricAJOONI (2025)BNHOLDINGS (2025)
Operating Cash Flow i-198.64M-2.59B
Operating Cash Flow % of Revenue i-17.3%-86.6%
Capital Expenditures i9.56MN/A
Free Cash Flow i-197.69M-315.40M
FCF Margin i-17.2%-10.5%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAJOONIBNHOLDINGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i172.24M97.77M
Float Shares i124.23M42.21M
% Held by Insiders iN/A77.40%
% Held by Institutions iN/A18.34%
% Held by Public iN/A4.26%

Dividend Analysis & Yield Comparison: Ajooni Biotech Ltd. vs BN Holdings Ltd

MetricAJOONIBNHOLDINGS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A